Please login to the form below
EU
This page shows the latest EU news and features for those working in and with pharma, biotech and healthcare.
FDA panel undermines Lilly and Incyte’s baricitinib hopes
Both doses of Lilly and Incyte’s drug are already approved in the EU, where it is sold as Olumiant, and the product brought in total revenues for Lilly of $46m
Latest news
-
Research Partnership adds to its team
Coffin, joins the group as its new director for the EU region following over 18 years’experience in the pharmaceutical sector.
-
Sanofi’s PD-1 inhibitor starts EU review for skin cancer
Sanofi’ s PD-1 inhibitor starts EU review for skin cancer. Cemiplimab could be the first PD-1-targeting drug approved for CSCC.
-
Takeda’s Alofisel becomes Europe’s first allogeneic stem cell therapy
approved allogeneic stem cell therapy set to hit the EU market.
-
AZ finally gets EU nod for Veltassa rival Lokelma
AZ finally gets EU nod for Veltassa rival Lokelma. And expects a US FDA verdict for the hyperkalaemia treatment later this year. ... challenge Vifor Pharma’s Veltassa (patiromer) which was approved in the EU last year and has been sold in the US since
-
Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal
This will be the third biosimilar Mundipharma and Celltrion has launched in the EU, following Remsima (infliximab) and Truxima (rituximab), biosimilars of Johnson and Johnson’s Remicade and Roche’s MabThera.
More from news
Approximately 112 fully matching, plus 1,196 partially matching documents found.
Latest Intelligence
-
Uncertainty, austerity and Brexit
The key point is that this is all happening now; where will the UK be in 2020 when we leave the EU? ... Brazil and India all seeking to attract global investment, at the same time as the UK seeks to break away from the EU market.
-
The threat of antimicrobial resistance
The DRIVE-AB final report is available at: http://drive-ab.eu/wp-content/uploads/2018/01/DRIVE-AB-Final-Report-Jan2018.pdf. Article by.
-
Brexit Means Brexit
Is that a finished product or an active ingredient? How are you going to move raw supplies from outside the EU? ... There are implications in non-EU markets too.”. There are also potential issues around CPPs (Certificate of a Pharmaceutical Product).
-
Health on instalment
Another EU drug, Strimvelis, targeting immune deficiency, retails for $665, 000.
-
Digital mania - a question of value
Anthony Rowbottom, research director and head of digital and innovation at Branding Science EU, has been active in the healthcare industry for 15 years - follow him on Twitter: @Arowbottom.
More from intelligence
Approximately 7 fully matching, plus 140 partially matching documents found.
Latest appointments
-
Open Access Consulting appoints new director
Hurrell joins the group from Evidera, where she worked for over a decade, most recently as vice president and EU practice lead, market access communications.
-
Trio of senior hires joins Syneos Health
the agency and will serve as the head of integrated communications for the EU, partnering with the firm’s customers who work with Syneos for their marketing communications campaigns.
-
Hanover Brussels appoints Aurélie Marchand as account director
Hanover Brussels has bolstered its policy team with a new senior hire in the form of Aurélie Marchand, who joins the communications and public affairs consultancy as its EU health account ... Coming from a country where market access and negotiations
-
RJW & Partners appoints new director
She joins the firm from pharma service provider ICON, where she served as principal and head of EU pricing and market access.
-
M3 appoints Simon Walker as director of education
M3 EU’s CEO Tim Ringrose said: “I’d like to welcome Simon as our Education Director, a key appointment for M3.
More from appointments
Approximately 2 fully matching, plus 58 partially matching documents found.
Latest from PMHub
-
Infographic: HCV EU
Infographic: HCV EU. Research findings from our Therapy HCV study shows that 28% of HCV patients in the EU are infected by sharing needles or drug equipment.
-
News: Therapy Watch HCV expands into 4 additional EU markets
News: Therapy Watch HCV expands into 4 additional EU markets. The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment
-
CASE STUDY: Providing Cost-effective Publication Planning Support to an EU-based Global Pharmaceutical Company
CASE STUDY: Providing Cost-effective Publication Planning Support to an EU-based Global Pharmaceutical Company. ... needs. . Providing Cost-effective Publication Planning Support to an EU-based Global Pharmaceutical Company.
-
Research Partnership launches new patient Living with Psoriasis 2017 (EU) report
Research Partnership launches new patient Living with Psoriasis 2017 (EU) report.
-
Research Partnership has published a new patient Living with Psoriasis (EU) report
Research Partnership has published a new patient Living with Psoriasis (EU) report.
More from PMHub
Approximately 2 fully matching, plus 142 partially matching documents found.
Featured jobs
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Account Manager – Med Comms – London
-
Salary TBC
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Medical Writer
-
Great salary and benefits
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Senior Medical Writer
-
Great salary and bebefits
-
Senior Programme Executive
-
Salary TBC
-
Scientific Director
-
Great salary and bebefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
Subscribe to our email news alerts
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
- The Holy Grail of HCP Access
- This is the data you need to gain access....
Quick links
Infographics
